ARCHIVES

OMB reviewing Administration’s Reauthorization Bill; NCI Special Authority Probably Will Remain

This article is from The Cancer Letter archive.

Vol. 14 No. 16 | April 15, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Alan Davis to Retire From ACS; Five Execs Keep Top Positions

September 10, 1993

SAIC Begins Transition Of Frederick Operations From Incumbent PRI

March 17, 1995

Obituary: Rajka Medenica, controversial Physician

December 5, 1997

Panel Recommends Peer Review “Fine Tuning” Changes Including Mandatory Service By All NIH Grantees

January 6, 1984

Funding Opportunities.

July 19, 2002